Improving the outcome for patients after osteoporotic femoral fractures - Improving the outcome for patients after osteoporotic femoral fracture

niversity of Leeds0 sites120 target enrollmentAugust 17, 2010

Overview

No summary available.

Registry

who.int

Start Date

August 17, 2010

End Date

TBD

Last Updated

7 years ago

Study Type

Interventional clinical trial of medicinal product

Sponsor

niversity of Leeds

•\- Patients with acute traumatic trochanteric or supracondylar femoral fractures and fragility fractures (i.e. sustained from standing height or less and radiological features of osteoporosis). \- Patients who are aged 55 or older.
•Are the trial subjects under 18? no
•Number of subjects for this age range: 0
•F.1\.2 Adults (18\-64 years) yes
•F.1\.2\.1 Number of subjects for this age range 0
•F.1\.3 Elderly (\>\=65 years) yes
•F.1\.3\.1 Number of subjects for this age range 0

•\- Patients with open fractures, pathological fractures, ‘floating knee’, associated patellar fractures or simultaneous bilateral fractures \- Patients with a known metabolic bone disease, rheumatoid arthritis or chronic renal failure \- Patients with dementia \- Patients with bone metastases or other malignant bone disease \- Patients taking steroids, strontium, biphosphonates or PTH \-Patients with oesophageal abnormalities, swallowing problems, hypocalcaemia, hypercalcemia. \- Women of child\-bearing age (\<55years), pregnant or breast feeding.